蒙牛(02319.HK)附屬斥30億人幣增持妙可藍多A
蒙牛乳業(02319.HK)公布,間接非全資附屬內蒙蒙牛斥近30億元人民幣,購入妙可藍多(600882.SH)不多於1.01億股股份,相當於每股29.71元人民幣。完成後,持股由約5%升至23.8%。
同日,內蒙蒙牛與上海妙可藍多的控股股東柴琇訂立合作協議。根據合作協議,柴女士同意,就一定數量的目標股份,在一定時間內放棄並促使其相關的控制實體放棄行使全部或部分表決權。
妙可藍多近年來奶酪業務高速增長,擁有豐富的奶酪產能和奶酪生產技術,已成長為境內奶酪行業龍頭企業。此次投資符合公司發展戰略,公司看好奶酪市場未來的發展前景,認同妙可藍多的長期發展潛力。經考慮以上因素後,董事會認為股份認購協議和合作協議的條款及其項下擬進行的交易為公平合理,且符合公司及股東的整體利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.